| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,973 |
5,202 |
$240K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,641 |
2,597 |
$174K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,277 |
3,136 |
$56K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,029 |
905 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,201 |
1,837 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,112 |
930 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
444 |
395 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
92 |
82 |
$4K |
| 92552 |
|
252 |
212 |
$3K |
| 99401 |
|
237 |
189 |
$2K |
| 96127 |
|
478 |
425 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
19 |
13 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
65 |
46 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,459 |
1,148 |
$997.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,661 |
2,089 |
$975.81 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
86 |
83 |
$850.00 |
| 99406 |
|
119 |
88 |
$778.36 |
| 36415 |
Collection of venous blood by venipuncture |
575 |
472 |
$773.13 |
| 99173 |
|
253 |
214 |
$762.04 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
743 |
517 |
$517.55 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$281.52 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
197 |
171 |
$173.96 |
| 87807 |
|
16 |
15 |
$173.05 |
| 81003 |
|
63 |
49 |
$86.10 |
| 1036F |
|
25 |
24 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,856 |
1,364 |
$0.00 |